National University Health System (NUHS)

• A collaboration was also made with Biopolis and NUS to study the molecular epidemiology of nephropathy secondary to type 2 diabetes
• Dr Subramaniam Tavintharan is also working with NUS on the mechanisms of simvastatin-induced hepotoxicity to study hepatic gene expression profiles to explain the pathogensis of hepatopathy.
• We have also had continuous collaboration with the Department of Biochemistry in NUS to study the genome wide transcriptomic study on HepG2 cells treated – with NUS Dept of Biochemistry
• Another collaboration with the Department of Biochemistry, NUS involves miRNA profiling of subjects with and without metabolic disorders